Pfizer Inc

Global stocks

What to watch in stocks in 2022

2021 was a year of surprises. Getting the details right in 2022 will be no easier.
Vaccine ETFs outperform Nasdaq and S&P500; offer diversified exposure to Covid - THE EDGE SINGAPORE

Funds

Vaccine ETFs outperform Nasdaq and S&P500; offer diversified exposure to Covid

A strategic option would be to invest in an exchange traded fund (ETF) with exposure to vaccine-related stocks.
Global race to recover from Covid-19 - THE EDGE SINGAPORE

Tong's Portfolio

Global race to recover from Covid-19

Last Tuesday, the UK became the first major Western country to start inoculating its population.
Global economic recovery will be stronger than expected - THE EDGE SINGAPORE

Tong's Portfolio

Global economic recovery will be stronger than expected

Amid all the grim Covid-19 headlines, stock prices have continued to move higher.
Pfizer, BioNTech plan filing as vaccine proves 95% effective - THE EDGE SINGAPORE

Covid-19

Pfizer, BioNTech plan filing as vaccine proves 95% effective

A third contender, from AstraZeneca and the University of Oxford, is expected to release trial results in the coming days.
We started positioning into cyclical stocks in the last few months - THE EDGE SINGAPORE

Tong's Portfolio

We started positioning into cyclical stocks in the last few months

Stock gains accelerated after Pfizer announced an interim analysis that its Covid-19 vaccine.
Pfizer's Covid-19 vaccine prevents 90% of infections in study - THE EDGE SINGAPORE

Covid-19

Pfizer's Covid-19 vaccine prevents 90% of infections in study

The news added more than US$500 billion ($674.04 billion) to the value of the MSCI All Country World Index.
×